Tech Center 4100 • Art Units: 3774 3791 4100
This examiner grants 41% of resolved cases
Andrew Eli Hoffpauir is an examiner in Tech Center 4100 and Art Unit 3774. He has 99 resolved cases. His allowance rate is 41.4 percent. This 41.4 percent rate indicates that less than half of the applications he reviews reach allowance. The 99 resolved cases provide a baseline for evaluating prosecution success with this examiner.
The interview lift is 52.1 percent. This 52.1 percent increase in allowance probability is exceptionally high, suggesting that interviews are a critical tool for applicants. For those facing the 41.4 percent allowance rate, an interview provides a substantial 52.1 percent lift. This strategy can be a decisive factor in the 99 cases he has handled.
The median time to allowance is 1441 days. This 1441 days pendency is a duration that practitioners should consider when filing. The combination of the 41.4 percent allowance rate and the 1441 days timeline defines the prosecution environment. Utilizing the 52.1 percent interview lift is a primary method for improving outcomes.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18767471 | POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) WITH IMPROVED PERFUSION SIGNAL FOR ADVANCED BIOSENSING | Final Rejection | Samsung Electronics Co., Ltd. |
| 18303265 | METHOD AND ELECTRONIC DEVICE FOR DETERMINING SKIN INFORMATION USING HYPER SPECTRAL RECONSTRUCTION | Non-Final OA | SAMSUNG ELECTRONICS CO., LTD. |
| 18932901 | Tactile-Feedback System and Method for Guidewire-Containing Medical Devices | Non-Final OA | Bard Access Systems, Inc. |
| 17854036 | PATIENT SUPPORT APPARATUS WITH SPECTROMETER | Non-Final OA | Stryker Corporation |
| 18963253 | SYSTEMS, DEVICES, AND METHODS FOR TIME-IN-RANGE AND MEAL-RELATED ANALYTE MONITORING | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18963914 | SAMPLE COLLECTION DEVICE AND SAMPLE PROCESSING DEVICE | Non-Final OA | Canon Kabushiki Kaisha |
| 18958945 | A SENSOR ARRANGEMENT FOR MOUNTING ON A GUIDEWIRE OR CATHETER | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18292643 | DETECTION OF SUBJECT RESPONSE TO MECHANICAL STIMULI IN THE MOUTH | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18044660 | Respiratory Feedback For Improved Exercise Performance | Final Rejection | QUALCOMM Incorporated |
| 17783468 | SYSTEM AND METHOD FOR DIAGNOSING PULSATILE TINNITUS AND OTHER BLOOD VESSEL DISORDERS | Final Rejection | The Regents of the University of California |
| 18686047 | INFORMATION PROCESSING APPARATUS, METHOD AND COMPUTER PROGRAM PRODUCT FOR MEASURING A LEVEL OF COGNITIVE DECLINE IN A USER | Final Rejection | Sony Group Corporation |
| 17932434 | SYSTEMS AND METHODS FOR ANESTHESIA DISPLAY | Non-Final OA | GE Precision Healthcare LLC |
| 17743806 | SECURELY EXCHANGING INFORMATION BETWEEN A MEDICAL DEVICE AND A MOBILE COMPUTING DEVICE USING VISUAL INDICATORS | Final Rejection | ZOLL Medical Corporation |
| 18633767 | METHOD AND SYSTEM FOR DETERMINING POST-EXERCISE RECOVERY SCORE USING PERSONALIZED CARDIAC MODEL | Final Rejection | Tata Consultancy Services Limited |
| 17504483 | SELF-COMPENSATED FUNCTIONAL PHOTOACOUSTIC MICROSCOPY | Non-Final OA | CITY UNIVERSITY OF HONG KONG |
| 18068400 | NOISE REDUCTION IN ANALYTE DATA | Final Rejection | Dexcom, Inc. |
| 18540229 | DIAGNOSTIC DEVICE FOR LOCAL INTRAVENOUS BIOMARKER MEASUREMENTS AND METHODS OF USE THEREOF | Non-Final OA | Cook Medical Technologies LLC |
| 18845461 | LOWER EXTREMITY VASCULAR LESION EVALUATION DEVICE AND LOWER EXTREMITY VASCULAR LESION EVALUATION METHOD | Non-Final OA | HAMAMATSU PHOTONICS K.K. |
| 18766493 | BODY ATTACHABLE UNIT FOR CONTINUOUS BLOOD GLUCOSE MEASUREMENT | Final Rejection | I-SENS, INC. |
| 18705271 | COGNITIVE FUNCTION EVALUATION SYSTEM AND LEARNING METHOD | Non-Final OA | OSAKA UNIVERSITY |
| 18280883 | ELECTROENCEPHALOGRAM (EEG) BASED TRANSCRANIAL MAGNETIC STIMULATION (TMS) NETWORKS | Non-Final OA | WAVE NEUROSCIENCE, INC. |
| 18196005 | Portable Kinematic Joint Tracking System | Non-Final OA | Orthosensor Inc. |
| 17620158 | METHOD AND SYSTEM FOR MEASURING EEG SIGNALS | Final Rejection | EEG-SENSE Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy